Journal Article

Inhibition of vinyl carbamate-induced mutagenicity and clastogenicity by the garlic constituent diallyl sulfone in F<sub>1</sub> (Big Blue<sup>®</sup> × A/J) transgenic mice

Lya G. Hernandez and Poh-Gek Forkert

in Carcinogenesis

Volume 28, issue 8, pages 1824-1830
Published in print August 2007 | ISSN: 0143-3334
Published online March 2007 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/bgm051
Inhibition of vinyl carbamate-induced mutagenicity and clastogenicity by the garlic constituent diallyl sulfone in F1 (Big Blue® × A/J) transgenic mice

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

Vinyl carbamate (VC) is a metabolite of ethyl carbamate (EC), a naturally occurring compound found in fermented foods and alcoholic beverages. CYP2E1 mediates the sequential oxidation of EC to VC and subsequently to the vinyl carbamate epoxide, which is believed to be the ultimate carcinogenic species. Here, we have tested the hypothesis that bioactivation of VC by CYP2E1 plays a central role in the development of its mutagenicity and clastogenicity, and further that inhibition of CYP2E1 by diallyl sulfone (DASO2) leads to diminution in their incidences. DASO2 is a garlic constituent that is oxidized by CYP2E1, leading to inactivation of this P450. F1 (Big Blue® × A/J) transgenic mice harboring the λ cII gene were used for in vivo identification and quantitation of mutations in the lung and small intestine. Mice were pre-treated with DASO2 (12.5–200 mg/kg, p.o.), treated 2 h later with VC (60 mg/kg, i.p.) and were killed 4 weeks later. Our results showed that pre-treatment of mice with DASO2 at doses of 50–200 mg/kg significantly decreased the VC-induced mutant frequencies (MFs) by 50–70%. In the small intestine, pre-treatment with 200 mg/kg of DASO2 decreased the MF by ∼40%. Clastogenicity, as assessed by the frequency of micronucleated reticulocytes, was significantly decreased (33–44%) by pre-treatment with DASO2 (50–200 mg/kg). These results demonstrated that bioactivation of VC by CYP2E1 plays a valid role in the development of mutagenicity and clastogenicity, and further that inhibition of this pathway by DASO2 produces a protective effect.

Journal Article.  6612 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.